---
figid: PMC6745797__12943_2019_1062_Fig2_HTML
figtitle: Intrinsic cancer cell pathways mediate the regulation of PD-L1 expression
  and MHC in EGFR-mutant NSCLC
organisms:
- NA
pmcid: PMC6745797
filename: 12943_2019_1062_Fig2_HTML.jpg
figlink: /pmc/articles/PMC6745797/figure/Fig2/
number: F2
caption: 'Intrinsic cancer cell pathways mediate the regulation of PD-L1 expression
  and MHC in EGFR-mutant NSCLC. Activation of EGFR may lead to downregulation of MHC
  expression through the MEK/ERK signaling pathway. In addition, activation of EGFR
  may influence expression of IFN-γR, generating intracellular signals that induce
  expression of the CIITA gene. CIITA is recruited to the MHC promoter, activating
  transcription. The net result is attenuation of CIITA and MHC molecule expression.
  In response to EGFR-TKIs, expression of CIITA and MHC genes is derepressed. In addition,
  EGFR-TKIs enhance MHC expression by inhibiting ERK activation. CIITA: class II major
  histocompatibility complex transactivator; TME: tumor microenvironment; MEK/ERK:
  extracellular signal–regulated kinase (ERK) kinase MEK; IFN-γR: interferon γ receptor;
  MHC: major histocompatibility complex; EGFR-TKIs: epidermal growth factor receptor
  tyrosine kinase inhibitors; EGFR: epidermal growth factor receptor; IFN-γ: interferon-γ'
papertitle: Role of the dynamic tumor microenvironment in controversies regarding
  immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC)
  with EGFR mutations.
reftext: Anqi Lin, et al. Mol Cancer. 2019;18:139.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9609425
figid_alias: PMC6745797__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6745797__F2
ndex: fbd509c8-deae-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6745797__12943_2019_1062_Fig2_HTML.html
  '@type': Dataset
  description: 'Intrinsic cancer cell pathways mediate the regulation of PD-L1 expression
    and MHC in EGFR-mutant NSCLC. Activation of EGFR may lead to downregulation of
    MHC expression through the MEK/ERK signaling pathway. In addition, activation
    of EGFR may influence expression of IFN-γR, generating intracellular signals that
    induce expression of the CIITA gene. CIITA is recruited to the MHC promoter, activating
    transcription. The net result is attenuation of CIITA and MHC molecule expression.
    In response to EGFR-TKIs, expression of CIITA and MHC genes is derepressed. In
    addition, EGFR-TKIs enhance MHC expression by inhibiting ERK activation. CIITA:
    class II major histocompatibility complex transactivator; TME: tumor microenvironment;
    MEK/ERK: extracellular signal–regulated kinase (ERK) kinase MEK; IFN-γR: interferon
    γ receptor; MHC: major histocompatibility complex; EGFR-TKIs: epidermal growth
    factor receptor tyrosine kinase inhibitors; EGFR: epidermal growth factor receptor;
    IFN-γ: interferon-γ'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - pd
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Hsp83
  - Gp93
  - sgg
  - Axn
  - gskt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Cdc37
  - hop
  - bsk
  - Dsor1
  - Mtk
  - Akt
  - CkIIbeta
  - CkIIbeta2
  - CkIIalpha
  - Erk7
  - rl
  - Stat92E
  - Mtor
  - Tor
  - Jra
  - Dif
  - dl
  - Rel
  - Mhc
  - zip
  - Myc
  - peb
  - dog
  - EGFR
  - AREG
  - EGF
  - TGFA
  - HBEGF
  - BTC
  - EREG
  - EPGN
  - IL6
  - CD274
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - GSK3B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CDC37
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - EPHB2
  - MAPK1
  - MAPK3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MTOR
  - CIITA
  - JUN
  - NFKB1
  - HLA-C
  - MYC
  - MPEG1
  - H
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
